Ticker
  • Untapable heads a field of nine in the $1 million Cotillion. Posted 12 hours ago
  • California Chrome draws the rail for the Pennsylvania Derby. Posted 13 hours ago
  • Sheikhzayedroad scoots up the rail for the Northern Dancer victory! Posted 2 days ago
  • Baltic Baroness wins the Prix Vermeille; Treve a disappointing 4th. Posted 2 days ago
  • Suntracer cashes in the Kentucky Turf Cup! Posted 3 days ago
  • Conquest Typhoon much the best in the Summer! Posted 3 days ago
  • Ball Dancing beats her stablemate to the wire in the Sands Point! Posted 3 days ago
  • 1st time Lasix and the U.S., Annecdote romps in the Noble Damsel! Posted 3 days ago
  • Conquest Harlanate rolls late in the Natalma! Posted 3 days ago
  • There will be a carryover of $59,132 when racing resumes Saturday at Los Alamitos.Posted 3 days ago

Gulfstream Backs Off Lasix Ban

Gulfstream Park owner Frank Stronach’s desire to outlaw the raceday use of Lasix will not go into effect during the upcoming meeting, track president Tim Ritvo said on Wednesday.

Stronach sent a letter to state regulators last month asking for their help to implement a program that would ultimately phase out all raceday medications at the track, including the elimination of Lasix at its 2011-2012 meet, which begins Dec. 3. But after conferring Tuesday in Tallahassee with members of the Florida Department of Business and Professional Regulations, which oversees all parimutuel racing in Florida, Ritvo said the state is not yet ready to make such a commitment.

“Our company’s position is to phase out raceday medications,” said Ritvo. “Frank’s beliefs are basically the same as those being echoed recently by the Jockey Club, Breeders’ Cup and Graded Stakes Committee. We asked the state to help us implement this program in the best interests of racing and they said they’d be willing to take up the matter at a later date following an open forum on the subject.”

Ritvo said he offered to hold that forum at Gulfstream Park during the upcoming meet.
Read More

 

comments powered by Disqus

Related Pages

Related Stories

Top Stories